- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Cancers, 11, 4
- Keyword
-
-
- Event
-
Veröffentlichung
- (where)
-
Greifswald
- (who)
-
Universität Greifswald
- (when)
-
2019
- Creator
-
Marx, Sascha
Xiao, Yong
Baschin, Marcel
Splittstöhser, Maximilian
Altmann, Robert
Moritz, Eileen
Jedlitschky, Gabriele
Bien-Möller, Sandra
Schroeder, Henry W.S.
Rauch, Bernhard H.
- DOI
-
10.3390/cancers11040569
- URN
-
urn:nbn:de:gbv:9-opus-29635
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
25.03.2025, 1:46 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Marx, Sascha
- Xiao, Yong
- Baschin, Marcel
- Splittstöhser, Maximilian
- Altmann, Robert
- Moritz, Eileen
- Jedlitschky, Gabriele
- Bien-Möller, Sandra
- Schroeder, Henry W.S.
- Rauch, Bernhard H.
- Universität Greifswald
Time of origin
- 2019
Other Objects (12)
Molecular adaptation and resistance mechanisms of human malignant glioma cells
Characterization of cancer treatment-related neurotoxicity in patients with malignant glioma
The Acidic Brain—Glycolytic Switch in the Microenvironment of Malignant Glioma
Regorafenib CSF penetration, efficacy, and MRI patterns in recurrent malignant glioma patients
Improving the Extent of Malignant Glioma Resection by Dual Intraoperative Visualization Approach
Vesicular stomatitis virus (VSV)-based systems for oncolytic virotherapy of malignant glioma
Gene therapy of malignant glioma with retroviral vectors and tumorinfiltrating progenitor cells
Pirfenidone, an inhibitor of TGF-beta expression in malignant glioma cell lines
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease
Second generation mtor inhibitors as a double-edged sword in malignant glioma treatment
Gene therapy of malignant glioma with retroviral vectors and tumor-infiltrating progenitor cells
Platelets as modulators of blood-brain barrier disruption and inflammation in the pathophysiology of ischemic stroke
Molecular adaptation and resistance mechanisms of human malignant glioma cells
Characterization of cancer treatment-related neurotoxicity in patients with malignant glioma
The Acidic Brain—Glycolytic Switch in the Microenvironment of Malignant Glioma
Regorafenib CSF penetration, efficacy, and MRI patterns in recurrent malignant glioma patients
Improving the Extent of Malignant Glioma Resection by Dual Intraoperative Visualization Approach
Vesicular stomatitis virus (VSV)-based systems for oncolytic virotherapy of malignant glioma
Gene therapy of malignant glioma with retroviral vectors and tumorinfiltrating progenitor cells
Pirfenidone, an inhibitor of TGF-beta expression in malignant glioma cell lines
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease
Second generation mtor inhibitors as a double-edged sword in malignant glioma treatment
Gene therapy of malignant glioma with retroviral vectors and tumor-infiltrating progenitor cells
Platelets as modulators of blood-brain barrier disruption and inflammation in the pathophysiology of ischemic stroke
Molecular adaptation and resistance mechanisms of human malignant glioma cells
Characterization of cancer treatment-related neurotoxicity in patients with malignant glioma
The Acidic Brain—Glycolytic Switch in the Microenvironment of Malignant Glioma
Regorafenib CSF penetration, efficacy, and MRI patterns in recurrent malignant glioma patients
Improving the Extent of Malignant Glioma Resection by Dual Intraoperative Visualization Approach
Vesicular stomatitis virus (VSV)-based systems for oncolytic virotherapy of malignant glioma
Gene therapy of malignant glioma with retroviral vectors and tumorinfiltrating progenitor cells
Pirfenidone, an inhibitor of TGF-beta expression in malignant glioma cell lines
Dabrafenib in patients with recurrent, BRAF V600E mutated malignant glioma and leptomeningeal disease
Second generation mtor inhibitors as a double-edged sword in malignant glioma treatment
Gene therapy of malignant glioma with retroviral vectors and tumor-infiltrating progenitor cells